Skip to main content

. 1972 Aug 5;3(5822):332–333. doi: 10.1136/bmj.3.5822.332

Ethambutol and a false-positive screening test for phaeochromocytoma.

PMCID: PMC1785546 PMID: 5046509

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

LITCHFIELD J. W., PEART W. S. Phaeochromocytoma with normal excretion of adrenaline and noradrenaline. Lancet. 1956 Dec 22;271(6956):1283–1284. doi: 10.1016/s0140-6736(56)91435-0. [DOI] [PubMed] [Google Scholar]
PLACE V. A., THOMAS J. P. Clinical pharmacology of ethambutol. Am Rev Respir Dis. 1963 Jun;87:901–904. doi: 10.1164/arrd.1963.87.6.901. [DOI] [PubMed] [Google Scholar]
Sheps S. G., Tyce G. M., Flock E. V., Maher F. T. Current experience in the diagnosis of pheochromocytoma. Circulation. 1966 Sep;34(3):473–483. doi: 10.1161/01.cir.34.3.473. [DOI] [PubMed] [Google Scholar]
Strauss I., Erhardt F. Ethambutol absorption, excretion and dosage in patients with renal tuberculosis. Chemotherapy. 1970 Mar;15(3):148–157. doi: 10.1159/000220678. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES